Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 1/20 | 0.40 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.40 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.40 |
| ▸ | GSR | P00390 | 1/20 | 0.37 |
| ▸ | NPY4R | P50391 | 7/20 | 0.36 |
| ▸ | NPY1R | P25929 | 5/20 | 0.36 |
| ▸ | DPP7 | Q9UHL4 | 3/20 | 0.36 |
| ▸ | NOS1 | P29475 | 1/20 | 0.36 |
| ▸ | RRM1 | P23921 | 1/20 | 0.36 |
| ▸ | OTC | P00480 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | NPY2R | P49146 | 4/20 | 0.34 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.33 |
| ▸ | DPP4 | P27487 | 1/20 | 0.33 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL301607 | 0.95 | GNAI3 (0.46) | GNAI3GNAO1GNAI1GSRNPY4R | |
| SCHEMBL11660913 | 0.95 | GNAI3 (0.46) | GNAI3GNAO1GNAI1GSRNPY4R | |
| SCHEMBL2057401 | 0.94 | GNAI3 (0.44) | GNAI3GNAO1GNAI1GSRNPY4R | |
| SCHEMBL28712062 | 0.94 | NPY4R (0.39) | GNAI3GNAO1GNAI1NPY4RNPY1R | |
| SCHEMBL9237239 | 0.94 | NPY4R (0.39) | GNAI3GNAO1GNAI1NPY4RNPY1R | |
| SCHEMBL288133 | 0.94 | NPY4R (0.39) | GNAI3GNAO1GNAI1NPY4RNPY1R | |
| Hydrochloric Acid SCHEMBL8039440 | 0.92 | NPY4R (0.38) | GNAI3GNAO1GNAI1NPY4RNPY1R | |
| Hydrochloric Acid SCHEMBL8040222 | 0.92 | NPY4R (0.38) | GNAI3GNAO1GNAI1NPY4RNPY1R | |
| SCHEMBL7543442 | 0.89 | GSR (0.43) | GNAI3GNAO1GNAI1GSRNPY4R | |
| SCHEMBL27722340 | 0.89 | NPY4R (0.37) | GNAI3GNAO1GNAI1NPY4RNPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2948775-B1 | COMPOSITIONS AND METHODS FOR DETECTING NEOPLASIA | US HEALTH (US) | 2018-10-03 | — | — | EP | claimed |
| US-20150344969-A1 | COMPOSITIONS AND METHODS FOR DETECTING NEOPLASIA | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES | 2015-12-03 | — | — | US | claimed |
| EP-2948775-A2 | COMPOSITIONS AND METHODS FOR DETECTING NEOPLASIA | The United States Of America,As Represented By The Secretary, Department Of Health & Human Services (US) | 2015-12-02 | — | — | EP | claimed |
| WO-2014116833-A2 | COMPOSITIONS AND METHODS FOR DETECTING NEOPLASIA | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 2014-07-31 | — | — | WO | claimed |
| EP-0507872-B1 | THE USE OF ARGININE AS AN IMMUNOSTIMULATOR | BRAUN MEDICAL INC (US) | 2000-04-26 | — | — | EP | claimed |
| WO-2026107124-A1 | GRAPH NEURAL NETWORK-BASED SYSTEM FOR METABOLOMIC NETWORK ANALYSIS AND EMBRYO IMPLANTATION PREDICTION | RHEA FERTILITY SINGAPORE PTE. LTD. (SG) | 2026-05-21 | — | — | WO | disclosed |
| US-10328162-B1 | CEST systems exhibiting a concentration independent responsiveness | BRACCO IMAGING S.P.A. (IT) | 2019-06-25 | — | — | US | disclosed |
| EP-2948775-B1 | COMPOSITIONS AND METHODS FOR DETECTING NEOPLASIA | US HEALTH (US) | 2018-10-03 | — | — | EP | disclosed |
| US-9518093-B2 | Topical formulation of arginine-rich cyclic antimicrobial peptides | NOVABIOTICS LIMITED (GB) | 2016-12-13 | — | — | US | disclosed |
| US-20160168203-A1 | Cyclic Antimicrobial Peptides | NOVABIOTICS LIMITED (GB) | 2016-06-16 | — | — | US | disclosed |
| US-20150344969-A1 | COMPOSITIONS AND METHODS FOR DETECTING NEOPLASIA | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES | 2015-12-03 | — | — | US | disclosed |
| EP-2948775-A2 | COMPOSITIONS AND METHODS FOR DETECTING NEOPLASIA | The United States Of America,As Represented By The Secretary, Department Of Health & Human Services (US) | 2015-12-02 | — | — | EP | disclosed |
| US-4376825-A | ENZYME-BOUND LIGANDS WITH FREE REACTIVE SITES WHICH CAN BIND RECEPTORS | SYVA COMPANY (US) | 1983-03-15 | — | — | US | disclosed |
| US-4282325-A | FOR AMPLIFICATION IN ASSAYS | SYVA COMPANY (US) | 1981-08-04 | — | — | US | disclosed |
| US-4203802-A | ENZYME BOUND TO AN ESTROGEN LIGAND | SYVA COMPANY (US) | 1980-05-20 | — | — | US | disclosed |
| US-4190496-A | RECEPTOR, LIGAND, AND ENZYME-BOUND | SYVA COMPANY (US) | 1980-02-26 | — | — | US | disclosed |
| US-4069214-A | ACRYLIC ESTER POLYMER, AMINO ACID CURING AGENT, COATING METALS, BONDING PLYWOOD, FINISHING TEXTILES | SANYO TRADING CO., LTD. (JA) | 1978-01-17 | — | — | US | disclosed |
| US-4067774-A | Compounds for enzyme amplification assay | SYVA COMPANY (US) | 1978-01-10 | — | — | US | disclosed |
| US-3975237-A | LIGANDS | SYVA COMPANY (US) | 1976-08-17 | — | — | US | disclosed |
| US-3966556-A | Compounds for enzyme amplification assay methadone analogs | SYVA COMPANY (US) | 1976-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10328162-B1 | CEST systems exhibiting a concentration independent responsiveness | NCS1, CERS2, LSS | GNAI3 682/4885GNAO1 2430/4885GNAI1 1433/4885 |
| US-20160168203-A1 | Cyclic Antimicrobial Peptides | VIP, FPR3, FPR1 | GNAI3 2212/4885GNAO1 4669/4885GNAI1 2455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.